{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T01:47:56Z","timestamp":1790387276909,"version":"4.1.0"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2009,11,11]],"date-time":"2009-11-11T00:00:00Z","timestamp":1257897600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinic Rev Allerg Immunol"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1007\/s12016-009-8183-5","type":"journal-article","created":{"date-parts":[[2009,11,19]],"date-time":"2009-11-19T21:07:37Z","timestamp":1258664857000},"page":"153-159","source":"Crossref","is-referenced-by-count":46,"title":["Complement Activation and Pregnancy Failure"],"prefix":"10.1007","volume":"39","author":[{"given":"Angela","family":"Tincani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilaria","family":"Cavazzana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamara","family":"Ziglioli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Lojacono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"De Angelis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierluigi","family":"Meroni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,11,11]]},"reference":[{"key":"8183_CR1","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.molimm.2005.06.017","volume":"43","author":"G Girardi","year":"2006","unstructured":"Girardi G, Bulla R, Salmon JE, Tedesco F (2006) The complement system in the pathophysiology of pregnancy. Mol Immunol 43:48\u201377","journal-title":"Mol Immunol"},{"key":"8183_CR2","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/S1471-4906(01)02031-2","volume":"22","author":"D Bainbridge","year":"2001","unstructured":"Bainbridge D, Ellis S, Le Boutellier P, Sargent I (2001) HLA-G remains a mystery. Trends Immunol 22:548\u2013552","journal-title":"Trends Immunol"},{"key":"8183_CR3","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1053\/plac.2002.0931","volume":"24","author":"P Bouteiller Le","year":"2003","unstructured":"Le Bouteiller P, Legrand-Abravanel F, Solier C (2003) Soluble HLA-G1 at the materno-foetal interface\u2014a review. Placenta 24:10\u201315","journal-title":"Placenta"},{"key":"8183_CR4","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1084\/jem.20050019","volume":"202","author":"I Guleria","year":"2005","unstructured":"Guleria I, Khosroshahi A, Ansari MJ, Habicht A et al (2005) A critical role for the programmed cell death ligand 1 in feto-maternal tolerance. J Exp Med 202:231\u2013227","journal-title":"J Exp Med"},{"key":"8183_CR5","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/ni1037","volume":"5","author":"VR Aluvihare","year":"2004","unstructured":"Aluvihare VR, Kallikourdis M, Betz AG (2004) Regulatory T cells mediate maternal tolerance to the fetus. Nat Immunol. 5:266\u2013271","journal-title":"Nat Immunol."},{"key":"8183_CR6","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/83183","volume":"2","author":"AL Mellor","year":"2001","unstructured":"Mellor AL, Sivakumar J, Chandler P et al (2001) Prevention of T cell-driven complement activation and inflammation by tryptophan catabolism during pregnancy. Nat Immunol 2:64\u201368","journal-title":"Nat Immunol"},{"key":"8183_CR7","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1126\/science.281.5380.1191","volume":"281","author":"DH Munn","year":"1998","unstructured":"Munn DH, Zhou M, Attwood JT et al (1998) Prevention of allogenic fetal rejection by tryptophan catabolism. Science 281:1191\u20131193","journal-title":"Science"},{"key":"8183_CR8","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1056\/NEJM200104053441406","volume":"344","author":"MJ Walport","year":"2001","unstructured":"Walport MJ (2001) Complement\u2014first of two parts. N Engl J Med 344:1058\u20131066","journal-title":"N Engl J Med"},{"key":"8183_CR9","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1172\/JCI119387","volume":"99","author":"Y Zhou","year":"1997","unstructured":"Zhou Y, Fisher SJ, Janatpour M et al (1997) Human cytotrophoblats adopt a vascular phenotype as they differentiate, a strategy for successful endovascular invasion? J Clin Invest 99:2139\u20132151","journal-title":"J Clin Invest"},{"key":"8183_CR10","first-page":"101","volume":"303","author":"R Bulla","year":"2005","unstructured":"Bulla R, Villa A, Bossi F et al (2005) VE-cadherin is a critical molecule for trophoblast-endothelial cell interaction in decidual spiral arteries. Exp Cell Res 303:101\u2013113","journal-title":"Exp Cell Res"},{"key":"8183_CR11","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1097\/00004347-199301000-00004","volume":"12","author":"A Andrew","year":"1993","unstructured":"Andrew A, Bulmer JN, Wells M et al (1993) Subinvolution of the uteroplacental arteries: an immunohistochemical study. Int J Gynecol Pathol 12:28\u201333","journal-title":"Int J Gynecol Pathol"},{"key":"8183_CR12","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1002\/eji.1830220635","volume":"22","author":"CH Holmes","year":"1992","unstructured":"Holmes CH, Simpson KL, Okada H et al (1992) Complement regulatory proteins at the feto-maternal interface during human placental development: distribution of CD59 by comparison with membrane cofactor protein (CD46) and decay accelerating factor (CD55). Eur J Immunol 22:1579\u20131585","journal-title":"Eur J Immunol"},{"key":"8183_CR13","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.4049\/jimmunol.144.8.3099","volume":"144","author":"CH Holmes","year":"1990","unstructured":"Holmes CH, Simpson KL, Wainwright SD et al (1990) Preferential expression of the complement regulatory protein decay accelerating factor at the fetomaternal interface during human pregnancy. J Immunol 144:3099\u20133105","journal-title":"J Immunol"},{"key":"8183_CR14","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1080\/0891693031000067331","volume":"36","author":"R Bulla","year":"2003","unstructured":"Bulla R, Bossi F, Radillo O et al (2003) Placental trophoblast and endothelial cells as target of maternal immune response. Autoimmunity 36:11\u201318","journal-title":"Autoimmunity"},{"key":"8183_CR15","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/0165-0378(91)90036-P","volume":"19","author":"BL Hsi","year":"1991","unstructured":"Hsi BL, Hunt JS, Atkinson JP (1991) Differential expression of complement regulatory proteins on subpopulations of human trophoblast cells. J Reprod Immunol 19:209\u2013223","journal-title":"J Reprod Immunol"},{"key":"8183_CR16","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1084\/jem.181.1.151","volume":"181","author":"YU Kim","year":"1995","unstructured":"Kim YU, Kinoshita T, Molina H et al (1995) Mouse complement regulatory protein Crry\/p65 uses the specific mechanisms of both human decay acceleration factor and membrane cofactor protein. J Exp Med 181:151\u2013159","journal-title":"J Exp Med"},{"key":"8183_CR17","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1126\/science.287.5452.498","volume":"287","author":"C Xu","year":"2000","unstructured":"Xu C, Mao D, Holers VM et al (2000) A critical role for murine complement regulator Crry in fetomaternal tolerance. Science 287:498\u2013501","journal-title":"Science"},{"key":"8183_CR18","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1002\/mrd.21013","volume":"76","author":"WN Chow","year":"2009","unstructured":"Chow WN, Lee YL, Wong PC et al (2009) Complement 3 deficiency impairs early pregnancy in mice. Mol Reprod Dev 76:647\u2013655","journal-title":"Mol Reprod Dev"},{"key":"8183_CR19","first-page":"175","volume":"56","author":"D Sinha","year":"1984","unstructured":"Sinha D, Wells M, Faulk WP (1984) Immunological studies of human placentae: complement components in pre-eclamptic chorionic villi. Clin Exp Immunol 56:175\u2013184","journal-title":"Clin Exp Immunol"},{"key":"8183_CR20","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/j.1365-2249.1990.tb05240.x","volume":"80","author":"F Tedesco","year":"1990","unstructured":"Tedesco F, Radillo O, Candussi G et al (1990) Immunohistochemical detection of terminal complement complex and S protein in normal and pre-eclamptic placentae. Clin Exp Immunol 80:236\u2013240","journal-title":"Clin Exp Immunol"},{"key":"8183_CR21","doi-asserted-by":"crossref","first-page":"6921","DOI":"10.4049\/jimmunol.173.11.6921","volume":"173","author":"F Bossi","year":"2004","unstructured":"Bossi F, Fischetti F, Pellis V et al (2004) Platelet-activating factor and kinin-dependent vascular leakage as a novel functional activity of the solubile terminal complement complex. J Immunol 173:6921\u20136927","journal-title":"J Immunol"},{"key":"8183_CR22","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1084\/jem.185.9.1619","volume":"185","author":"F Tedesco","year":"1997","unstructured":"Tedesco F, Pausa M, Nardon B, Introna M, Mantovani A, Dobrina A (1997) The cytolytically inactive terminal complement complex activates endothelial cells to express adhesion molecules and tissue factor procoagulant activity. J Exp Med 185:1619\u20131627","journal-title":"J Exp Med"},{"key":"8183_CR23","doi-asserted-by":"crossref","first-page":"3809","DOI":"10.1016\/S0021-9258(19)39666-8","volume":"265","author":"KK Hamilton","year":"1990","unstructured":"Hamilton KK, Hattori R, Esmon CT, Sims PJ (1990) Complement proteins C5b\u2013C9 induce vesciculation of the endothelial plasma membrane and expose catalytic surface for assembly of the prothrombinase enzyme complex. J Biol Chem 265:3809\u20133814","journal-title":"J Biol Chem"},{"key":"8183_CR24","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.ajog.2007.10.793","volume":"198","author":"AM Lynch","year":"2008","unstructured":"Lynch AM, Murphy JR, Byers T et al (2008) Alternative complement pathway activation fragment Bb in early pregnancy as a predictor of preeclampsia. Am J Gynecol 198:385\u2013389","journal-title":"Am J Gynecol"},{"key":"8183_CR25","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1056\/NEJMoa031884","volume":"350","author":"RJ Levine","year":"2004","unstructured":"Levine RJ, Maynard SE, Qian C et al (2004) Circulating angiogenic factors and the risk of preeclampsia. N Eng J Med 350:672\u2013683","journal-title":"N Eng J Med"},{"key":"8183_CR26","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1055\/s-2006-956773","volume":"25","author":"R Romero","year":"2007","unstructured":"Romero R, Espinoza J, Goncalves LF et al (2007) The role of inflammation and infection in preterm birth. Semin Reprod Med 25:21\u201339","journal-title":"Semin Reprod Med"},{"key":"8183_CR27","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/0198-8859(91)90030-D","volume":"30","author":"JM Risk","year":"1991","unstructured":"Risk JM, Flanagan BF, Johnson PM (1991) Polymorphism of the human CD46 gene in normal and in recurrent spontaneous abortion. Hum Immunol 30:162\u2013167","journal-title":"Hum Immunol"},{"key":"8183_CR28","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1006\/clin.1995.1023","volume":"74","author":"DS Cunningham","year":"1995","unstructured":"Cunningham DS, Tichenor JR (1995) Decay-acceleration factor protects human trophoblast from complement-mediated attack. Clin Immunol Immunopathol 74:156\u2013161","journal-title":"Clin Immunol Immunopathol"},{"key":"8183_CR29","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1161\/01.HYP.0000187899.34379.b0","volume":"46","author":"C Lam","year":"2005","unstructured":"Lam C, Lim KH, Sa K (2005) Circulating angiogenic factors in the pathogenesis and prediction of preeclampsia. Hypertension 46:1077\u20131085","journal-title":"Hypertension"},{"key":"8183_CR30","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1084\/jem.20061022","volume":"203","author":"G Girardi","year":"2006","unstructured":"Girardi G, Yarolin D, Thurman JM et al (2006) Complement activation induces dysregulation of angiogenic factors and causes fetal rejection and growth retardation. JEM 203:2165\u20132175","journal-title":"JEM"},{"key":"8183_CR31","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1097\/01.moh.0000130313.95291.4a","volume":"11","author":"PG Groot de","year":"2004","unstructured":"de Groot PG, Derksen RH (2004) Anti-phospholipid antibodies: update on detection, pathophysiology, and treatment. Curr Opin Hematol 11:165\u2013169","journal-title":"Curr Opin Hematol"},{"key":"8183_CR32","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/S0002-9378(11)90700-5","volume":"163","author":"DW Branch","year":"1990","unstructured":"Branch DW, Dudley DJ, Mitchell MD et al (1990) Immunoglobulin G fractions from patients with antiphospholipid antibodies cause fetal death in BALB\/c mice: a model for autoimmune fetal loss. Am J Obstet Gynecol 163:210\u2013216","journal-title":"Am J Obstet Gynecol"},{"key":"8183_CR33","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1073\/pnas.96.9.5164","volume":"96","author":"M Blank","year":"1999","unstructured":"Blank M, Shoenfeld Y, Cabilly S et al (1999) Prevention of experimental antiphopholipid syndrome and endothelial cell activation by synthetic peptides. Proc Natl Acad Sci USA 96:516\u2013518","journal-title":"Proc Natl Acad Sci USA"},{"key":"8183_CR34","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/j.1365-3083.1995.tb03588.x","volume":"41","author":"A Piona","year":"1995","unstructured":"Piona A, La Rosa L, Tincani A et al (1995) Placental thrombosis and fetal loss after passive transfer of mouse lupus monoclonal or human polyclonal anti-cardiolipin antibodies in pregnant naive BALB\/c mice. Scand J Immunol 41:427\u2013432","journal-title":"Scand J Immunol"},{"key":"8183_CR35","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1002\/1529-0131(199806)41:6<1026::AID-ART9>3.0.CO;2-1","volume":"41","author":"W Ikematsu","year":"1998","unstructured":"Ikematsu W, Luan FL, La Rosa L et al (1998) Human anticardiolipin monoclonal autoantibodies cause placental necrosis and fetal loss in BALB\/c mice. Arthritis Rheum 41:1026\u20131039","journal-title":"Arthritis Rheum"},{"key":"8183_CR36","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1055\/s-0028-1082267","volume":"34","author":"SS Pierangeli","year":"2008","unstructured":"Pierangeli SS, Chen PP, Raschi E et al (2008) Antiphosholipid antibodies and the antiphosphoipid syndrome: pathogenic mechanisms. Semin Thromb Hemost 34:236\u2013250","journal-title":"Semin Thromb Hemost"},{"key":"8183_CR37","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jaut.2007.11.014","volume":"30","author":"PL Meroni","year":"2008","unstructured":"Meroni PL (2008) Pathogenesis of antiphospholipid syndrome: an additional example of the mosaic of autoimmunity. J Autoimmun 30:99\u2013103","journal-title":"J Autoimmun"},{"key":"8183_CR38","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jaut.2008.11.002","volume":"32","author":"V Angelis De","year":"2009","unstructured":"De Angelis V, Scurati S, Raschi E, Liutkus A, Belot A, Borghi MO et al (2009) Proinflammatory genotype as a risk factor for aPL-associated thrombosis: report of a family with multiple anti-phospholipid positive members. J Autoimmun 32:60\u201363","journal-title":"J Autoimmun"},{"key":"8183_CR39","doi-asserted-by":"crossref","unstructured":"Cugno M, Borghi MO, Lonati LM, Ghiadoni L, Gerosa M, Grossi C et al (2009) Patients with antiphospholipid sindrome display endothelial perturbation. J Autoimmun (in press)","DOI":"10.1016\/j.jaut.2009.07.004"},{"key":"8183_CR40","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1093\/intimm\/dxh166","volume":"16","author":"M Bohgaki","year":"2004","unstructured":"Bohgaki M, Atsumi T, Yamashita Y, Yasuda S, Sakai Y, Furusaki A et al (2004) The p38 mitogen-activated protein kinase (MAPK) pathway mediates induction of the tissue factor gene in monocytes stimulated with human monoclonal anti-beta2Glycoprotein I antibodies. Int Immunol 16:1633\u20131641","journal-title":"Int Immunol"},{"key":"8183_CR41","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1172\/JCI118276","volume":"96","author":"R Simantov","year":"1995","unstructured":"Simantov R, La Sala JM, Lo SK, Gharavi AE, Sammaritano LR, Salmon JE et al (1995) Activation of cultured vascular endothelial cells by antiphospholipid antibodies. J Clin Invest 96:2211\u20132219","journal-title":"J Clin Invest"},{"key":"8183_CR42","first-page":"179","volume":"13","author":"N Papa Del","year":"1995","unstructured":"Del Papa N, Guidali L, Spatola L, Bonara P, Borghi MO, Tincani A et al (1995) Relationship between anti-phospholipid and anti-endothelial cell antibodies III: beta 2 glycoprotein I mediates the antibody binding to endothelial membranes and induces the expression of adhesion molecules. Clin Exp Rheumatol 13:179\u2013185","journal-title":"Clin Exp Rheumatol"},{"key":"8183_CR43","doi-asserted-by":"crossref","first-page":"2870","DOI":"10.1002\/1529-0131(200112)44:12<2870::AID-ART475>3.0.CO;2-Y","volume":"44","author":"PL Meroni","year":"2001","unstructured":"Meroni PL, Raschi E, Testoni C, Tincani A, Balestrieri G, Molteni R et al (2001) Statins prevent endothelial cell activation induced by antiphospholipid (anti-beta2-glycoprotein I) antibodies: effect on the proadhesive and proinflammatory phenotype. Arthritis Rheum 44:2870\u20132878","journal-title":"Arthritis Rheum"},{"key":"8183_CR44","doi-asserted-by":"crossref","first-page":"4209","DOI":"10.4049\/jimmunol.168.8.4209","volume":"168","author":"CS Cho","year":"2002","unstructured":"Cho CS, Cho ML, Chen PP, Min SY, Hwang SY, Park KS et al (2002) Antiphospholipid antibodies induce monocyte chemoattractant protein-1 in endothelial cells. J Immunol 168:4209\u20134215","journal-title":"J Immunol"},{"key":"8183_CR45","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1172\/JCI118854","volume":"98","author":"S Horkko","year":"1996","unstructured":"Horkko S, Miller E, Dudl E et al (1996) Antiphospholipid antibodies are directed against epitopes of oxidized phospholipids: recognition of cardiolipin by monoclonal antibodies to epitopes of oxidized low density lipoprotein. J Clin Invest 98:815\u2013825","journal-title":"J Clin Invest"},{"key":"8183_CR46","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1191\/0961203304lu2001oa","volume":"13","author":"PL Meroni","year":"2004","unstructured":"Meroni PL, di Simone N, Testoni C, D'Asta M, Acaia B, Caruso A (2004) Antiphospholipid antibodies as cause of pregnancy loss. Lupus 13:649\u2013652","journal-title":"Lupus"},{"key":"8183_CR47","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1093\/humupd\/dml051","volume":"13","author":"N Simone Di","year":"2007","unstructured":"Di Simone N, Meroni PL, D'Asta M, Di Nicuolo F, D'Alessio MC, Caruso A (2007) Pathogenic role of anti-{beta}2-glycoprotein I antibodies on human placenta: functional effects related to implantation and roles of heparin. Hum Reprod Update 13:189\u2013196","journal-title":"Hum Reprod Update"},{"key":"8183_CR48","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1084\/jem.200116116","volume":"1995","author":"VM Holers","year":"2002","unstructured":"Holers VM, Girardi G, Mo L et al (2002) C3 activation is required for anti-phospholipid antibody-induced fetal loss. J Exp Med 1995:211\u2013220","journal-title":"J Exp Med"},{"key":"8183_CR49","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1172\/JCI200318817","volume":"112","author":"G Girardi","year":"2004","unstructured":"Girardi G, Berman J, Redecha P, Spruce L, Thurman JM, Kraus D, Hollmann TJ et al (2004) Complement C5a receptors and neutrophils mediate fetal injury in the antiphosholipid syndrome. J Clin Invest 112:1644\u20131654","journal-title":"J Clin Invest"},{"key":"8183_CR50","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1038\/nm1121","volume":"10","author":"G Girardi","year":"2004","unstructured":"Girardi G, Redecha P, Salmon JE (2004) Heparin prevents antiphospholipid antibody-induced fetal loss by inhibiting complement activation. Nat Med 10:1222\u20131226","journal-title":"Nat Med"},{"key":"8183_CR51","doi-asserted-by":"crossref","first-page":"485","DOI":"10.4049\/jimmunol.174.1.485","volume":"174","author":"J Berman","year":"2005","unstructured":"Berman J, Girardi G, Salmon J (2005) TNF-\u03b1 is a critical effector and a target for therapy in antiphospholipid antibody-induced pregnancy loss. J Immunol 174:485\u2013490","journal-title":"J Immunol"},{"key":"8183_CR52","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1002\/art.20105","volume":"50","author":"RHWM Derksen","year":"2004","unstructured":"Derksen RHWM, Khamashta MA, Branch DW (2004) Management of the obstetric antiphospholipid syndrome. Arthritis Rheum 50:1028\u20131039","journal-title":"Arthritis Rheum"},{"key":"8183_CR53","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1038\/ncprheum0432","volume":"3","author":"JE Salmon","year":"2007","unstructured":"Salmon JE, Girardi G, Lockshin MD (2007) The antiphospholipid syndrome as a disorder initiated by inflammation: implications for the therapy of pregnant patients. Nat Clin Pract Rheumatol 3:140\u2013147","journal-title":"Nat Clin Pract Rheumatol"},{"issue":"supplement","key":"8183_CR54","doi-asserted-by":"crossref","first-page":"S404","DOI":"10.1016\/j.semarthrit.2007.09.006","volume":"58","author":"Y Martinez de la Torre","year":"2008","unstructured":"Martinez de la Torre Y et al (2008) Pregnant naive mice are protected from APL-induced fetal loss by the injection of a synthetic peptide (TIFI) mimicking the beta2GPI PL-binding site. Arthritis Rheum 58(supplement):S404","journal-title":"Arthritis Rheum"},{"key":"8183_CR55","first-page":"362","volume-title":"Placental pathology in antiphospholipid syndrome in Hughes\u2019 Syndrome","author":"AL Park","year":"2006","unstructured":"Park AL (2006) Placental pathology in antiphospholipid syndrome in Hughes\u2019 Syndrome. MA Khamashta editor, Springer-Verlag, London, p 362"},{"key":"8183_CR56","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1182\/blood-2007-01-070631","volume":"110","author":"P Redecha","year":"2007","unstructured":"Redecha P et al (2007) Tissue factor: a link between C5a and neutrophil activation in antiphospholipid antibody induced fetal injury. Blood 110:2423\u20132431","journal-title":"Blood"},{"key":"8183_CR57","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.placenta.2005.04.006","volume":"27","author":"S Stone","year":"2006","unstructured":"Stone S, Pijnenborg R, Vercruysse L et al (2006) The placental bed in pregnancies complicated by primary antiphospholipid syndrome. Placenta 27:457\u2013467","journal-title":"Placenta"},{"key":"8183_CR58","first-page":"3453","volume":"118","author":"P Redecha","year":"2008","unstructured":"Redecha P, Franzke CW, Ruf W, Mackman N, Girardi G (2008) Neutrophil activation by the tissue factor\/Factor VIIa\/PAR2 axis mediates fetal death in a mouse model of antiphospholipid syndrome. J Clin Invest 118:3453\u20133461","journal-title":"J Clin Invest"},{"key":"8183_CR59","first-page":"216","volume":"12","author":"JL Wei","year":"2007","unstructured":"Wei JL, Cui HM, Ma CY (2007) Simvastatin inhibits tissue factor and plasminogen activator inhibitor-1 secretion by peripheral blood mononucelar cells in patients with primary nephrotic syndrome. Eur J Med Res 12:216\u2013221","journal-title":"Eur J Med Res"},{"key":"8183_CR60","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1111\/j.1538-7836.2005.01262.x","volume":"3","author":"SS Pierangeli","year":"2005","unstructured":"Pierangeli SS, Ferrara DE (2005) More on. fluvastatin inhibits up-regulation of tissue factor expression by antiphospholipid antibodies on endothelial cells. J Thromb Haemost 3:1112\u20131113","journal-title":"J Thromb Haemost"},{"key":"8183_CR61","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1161\/CIRCULATIONAHA.106.660134","volume":"115","author":"M Cudmore","year":"2007","unstructured":"Cudmore M et al (2007) Negative regulation of soluble Flt-1 and soluble endoglin release by heme oxygenase-1. Circulation 115:1789\u20131797","journal-title":"Circulation"},{"key":"8183_CR62","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.jaut.2007.02.013","volume":"28","author":"I Cavazzana","year":"2007","unstructured":"Cavazzana I, Nebuloni M, Cetin I et al (2007) Complement activation in antiphospholipid syndrome: a clue for an inflammatory process? J Autoimmun 28:160\u2013164","journal-title":"J Autoimmun"},{"key":"8183_CR63","unstructured":"Gerosa M et al (2009) Complement involvement in antiphospholipid antibody-mediated placental damage: prospective study in APS pregnant women. Ann Rheum Dis (in press)"},{"key":"8183_CR64","first-page":"455","volume":"10","author":"WD Davis","year":"1992","unstructured":"Davis WD, Brey RL (1992) Antiphospholipid antibodies and complement activation in patients with cerebral ischemia. Clin Exp Rheumatol 10:455\u2013460","journal-title":"Clin Exp Rheumatol"},{"key":"8183_CR65","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1191\/096120399678847777","volume":"8","author":"J Carbone","year":"1999","unstructured":"Carbone J, Orera M, Rodriguez-Mahou M, Rodriguez-Perez C, Sanchez-Ramon S, Seoane E et al (1999) Immunological abnormalities in primary APS evolving into SLE: 6\u00a0years follow-up in women with repeated pregnancy loss. Lupus 8:274\u2013278","journal-title":"Lupus"},{"key":"8183_CR66","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1191\/0961203304lu1080oa","volume":"13","author":"M Ramos-Casals","year":"2004","unstructured":"Ramos-Casals M, Campoamor MT, Chamorro A, Salvador G, Segura S, Botero JC et al (2004) Hypocomplementemia in systemic lupus erythematosus and primary antiphospholipid syndrome: prevalence and clinical significance in 667 patients. Lupus 13:777\u2013783","journal-title":"Lupus"},{"issue":"Supplement","key":"8183_CR67","first-page":"S796","volume":"54","author":"K Oku","year":"2006","unstructured":"Oku K, Atsumi T, Sakai Y, Kataoka H, Horita T, Yasuda S et al (2006) Significance of hypocomplementemia in patients with primary antiphospholipid syndrome: a correlation to elevated plasma tumor necrosis factor alfa levels. Arthritis Rheum 54(Supplement):S796","journal-title":"Arthritis Rheum"},{"key":"8183_CR68","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1136\/ard.2008.090670","volume":"68","author":"K Oku","year":"2009","unstructured":"Oku K, Atsumi T, Bohgaki M et al (2009) Complement activation in patients with primary antiphospholipid syndrome. Ann Rheum Dis 68:1030\u20131035","journal-title":"Ann Rheum Dis"},{"key":"8183_CR69","first-page":"1768","volume":"15","author":"WA Wilson","year":"1998","unstructured":"Wilson WA, Perez MC, Michalski JP, Armatis PE (1998) Cardiolipin antibodies and null alleles of C4 in black Americans with systemic lupus erythematosus. J Rheumatol 15:1768\u20131772","journal-title":"J Rheumatol"}],"container-title":["Clinical Reviews in Allergy &amp; Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-009-8183-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12016-009-8183-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-009-8183-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,27]],"date-time":"2023-05-27T16:25:24Z","timestamp":1685204724000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12016-009-8183-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,11,11]]},"references-count":69,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["8183"],"URL":"https:\/\/doi.org\/10.1007\/s12016-009-8183-5","relation":{},"ISSN":["1080-0549","1559-0267"],"issn-type":[{"value":"1080-0549","type":"print"},{"value":"1559-0267","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,11,11]]}}}